Clearbridge Health (FRA:5C6) Buyback Yield %: -29.22 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Clearbridge Health Buyback Yield %?

Clearbridge Health FRA:5C6 Buyback Yield % is -29.22 as of Aug. 24, 2026. The stock has 4 warning signs investors should review. Among 81 Medical Diagnostics & Research companies, Clearbridge Health ranks worse than 77.78% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Clearbridge Health's current buyback yield was -29.22%.

Clearbridge Health Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Clearbridge Health's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearbridge Health Buyback Yield % Chart

Clearbridge Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -55.94 -28.91

Clearbridge Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -29.66 0.00 -21.85 -58.44

FRA:5C6 vs TMO, DHR, IDXX: Buyback Yield % Comparison

For the Diagnostics & Research subindustry, Clearbridge Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearbridge Health Buyback Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's Buyback Yield % falls into.


Clearbridge Health Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Clearbridge Health's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.242) / 4.295821
=-28.91%

Clearbridge Health's annualized Buyback Yield for the quarter that ended in Jun. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 2.538) / 3.2218655
=-78.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -29.22 mean?
Clearbridge Health (FRA:5C6) has a Buyback Yield % of -29.22 as of Aug. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Clearbridge Health and its competitors. According to the industry distribution chart, Clearbridge Health ranks #63 out of 81 companies in the Medical Diagnostics & Research industry, placing it in the top 77.8%.
Is Clearbridge Health's Buyback Yield % too high?
Clearbridge Health's current Buyback Yield % is -29.22. Based on the distribution chart, Clearbridge Health ranks #63 out of 81 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Clearbridge Health's Buyback Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clearbridge Health ranks #63 out of 81 companies for Buyback Yield %. This places Clearbridge Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Clearbridge Health and its competitors. Clearbridge Health's current Buyback Yield % is -29.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearbridge Health stock overvalued right now?
Clearbridge Health (FRA:5C6) has a current Buyback Yield % of -29.22. The current Buyback Yield % is -29.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Clearbridge Health (FRA:5C6), the current Buyback Yield % is -29.22 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clearbridge Health Business Description

Other Exchanges 1H3:Singapore
Address 37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments are Strategic investments; Others ; Medical clinics; Corporate segment and Investment. It derives key revenue from the Medical clinics segment. The medical clinics/centres segment involves the provision of general medical, dental and clinical services and distribution of the medical and pharmaceutical products. The group has a business presence in Singapore, Philippines, Hong Kong, Malaysia and others.